OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
8.18
-0.20 (-2.39%)
Dec 23, 2024, 4:00 PM EST - Market closed

OnKure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Sep '24 Dec '23 Dec '22
Net Income
-44.69-35.31-29.51
Depreciation & Amortization
0.580.560.39
Stock-Based Compensation
2.10.20.05
Change in Accounts Payable
6.711.712.65
Change in Other Net Operating Assets
0.39-1.71-0.53
Operating Cash Flow
-34.78-34.55-26.95
Capital Expenditures
-0.07-0.25-1.13
Investing Cash Flow
-0.07-0.25-1.13
Issuance of Common Stock
0.030.070.34
Other Financing Activities
-0.14-0.72-1.38
Financing Cash Flow
5.8953.1326.47
Net Cash Flow
-28.9618.33-1.62
Free Cash Flow
-34.85-34.79-28.09
Free Cash Flow Per Share
-2.61-2.89-
Levered Free Cash Flow
--22.69-
Unlevered Free Cash Flow
--22.69-
Change in Net Working Capital
-0.12-
Source: S&P Capital IQ. Standard template. Financial Sources.